TechCrunch

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

This is a short WorldPing brief. The full report was published by TechCrunch.

Read the full report at TechCrunch

More coverage: all technology news on WorldPing.

Related news